Latest Market Research Reports

  In Vitro Diagnostics Industry The global   in vitro diagnostics market   size was valued at USD 108.30 billion in 2024 and is projected to grow at a CAGR of 5.62% from 2025 to 2030. This growth is largely driven by the rising demand for accurate, rapid, and personalized diagnostic solutions. Several factors contribute to the expansion of the market, including the growing prevalence of chronic and infectious diseases, technological advancements in diagnostic tools, and the increasing focus on value-based healthcare models that emphasize early detection and preventive care. Additionally, the integration of digital health, artificial intelligence (AI), and data analytics into diagnostic platforms is enhancing test accuracy and aiding clinical decision-making. The expansion of point-of-care (POC) testing, personalized medicine, and increased preparedness for future pandemics are also playing key roles in driving market penetration and creating substantial opportunities for ...

In Vitro Diagnostics Industry Overview The global  i n vitro diagnostics market  size is expected to reach USD 113.38 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 0.2% over the forecast period driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users. In Vitro Diagnostics Market Segmentation Grand View Research has segmented the ...